English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Marketing
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Marketing
Patient Daily
| Apr 23, 2025
Senior Partner of Medfluence Advisors on ASCENT conference: We're 'empowering practice administrators with real-world tools'
+
Marketing
Patient Daily
| Apr 23, 2025
Founder of Medfluence Advisors on SNL copycat skit: 'We’re not mad. We’re flattered'
+
Marketing
Patient Daily
| Mar 14, 2025
Founder of Medfluence Advisors on healthcare marketing: 'The patient journey is more complex than ever'
+
Marketing
Patient Daily News Service
| Jun 26, 2024
Patients Come First announces Kasia Mulligan as national spokesperson
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Marketing
Patient Daily
| Nov 29, 2023
Yale New Haven Health System doctor: ‘It’s very important for us as a healthcare system to get to know our patients’
+
Marketing
Patient Daily
| Nov 10, 2023
Mayo Clinic dermatologist: 'Our findings suggest the need for a relatively high degree of suspicion of skin cancer at sites with lymphedema'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
